Sutro Biopharma (STRO) Debt Ratio (2017 - 2023)

Sutro Biopharma (STRO) has 7 years of Debt Ratio data on file, last reported at 0.01 in Q4 2023.

• For the quarter ending Q4 2023, Debt Ratio fell 78.42% year-over-year to 0.01; the trailing twelve-month figure through Dec 2023 stood at 0.01 (down 78.42% YoY), and the FY2023 full-year result was 0.01, down 78.42% from the prior year.
• Debt Ratio fell to 0.01 in Q4 2023, from 0.02 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.16 in Q1 2020 to a low of 0.01 in Q4 2023.
• A 5-year average of 0.06 and a median of 0.07 in 2019 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio jumped 122.78% in 2020 and tumbled 78.42% in 2023, its largest moves.
• Tracing STRO's Debt Ratio over 5 years: stood at 0.06 in 2019, then dropped by 1.39% to 0.06 in 2020, then gained by 18.11% to 0.07 in 2021, then plunged by 45.64% to 0.04 in 2022, then sank by 78.42% to 0.01 in 2023.
• Business Quant data shows STRO's Debt Ratio at 0.01 in Q4 2023, 0.02 in Q3 2023, and 0.02 in Q2 2023.